A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia

被引:72
|
作者
Skeith, Leslie [1 ,2 ,3 ]
Carrier, Marc [1 ,2 ,3 ,4 ]
Kaaja, Risto [5 ,6 ]
Martinelli, Ida [7 ]
Petroff, David [8 ]
Schleussner, Ekkehard [9 ]
Laskin, Carl A. [10 ,11 ,12 ]
Rodger, Marc A. [1 ,2 ,3 ,4 ,13 ]
机构
[1] Univ Ottawa, Div Hematol, Ottawa Blood Dis Ctr, Ottawa, ON, Canada
[2] Univ Ottawa, Dept Med, Ottawa, ON, Canada
[3] Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada
[4] Ottawa Gen Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON K1H 8L6, Canada
[5] Univ Turku, Dept Med, Turku, Finland
[6] Turku Univ Hosp, FIN-20520 Turku, Finland
[7] Osped Maggiore Policlin, Fdn Ist Ricovero & Cura Carattere Sci Ca Granda, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[8] Univ Leipzig, Clin Trial Ctr, D-04109 Leipzig, Germany
[9] Friedrich Schiller Univ Hosp, Dept Obstet & Gynecol, Jena, Germany
[10] LifeQuest Ctr Reprod Med, Toronto, ON, Canada
[11] Univ Toronto, Dept Med, Toronto, ON, Canada
[12] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada
[13] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada
关键词
LOW-DOSE ASPIRIN; RECURRENT MISCARRIAGE; CONSENSUS STATEMENT; FETAL LOSS; MULTICENTER; ASSOCIATION; DEFINITION; ANTIBODIES; DISEASE; TRIAL;
D O I
10.1182/blood-2015-12-626739
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We performed a meta-analysis of randomized controlled trials comparing low-molecular-weight heparin (LMWH) vs no LMWH in women with inherited thrombophilia and prior late (>= 10 weeks) or recurrent early (<10 weeks) pregnancy loss. Eight trials and 483 patients met our inclusion criteria. There was no significant difference in livebirth rates with the use of LMWH compared with no LMWH (relative risk, 0.81; 95% confidence interval, 0.55-1.19; P = .28), suggesting no benefit of LMWH in preventing recurrent pregnancy loss in women with inherited thrombophilia.
引用
收藏
页码:1650 / 1655
页数:6
相关论文
共 50 条
  • [21] ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia - study protocol for a randomized controlled trial
    Paulien G de Jong
    Siobhan Quenby
    Kitty WM Bloemenkamp
    Babette AM Braams-Lisman
    Jan Peter de Bruin
    Arri Coomarasamy
    Michele David
    Maria T DeSancho
    Olivier WH van der Heijden
    Annemieke Hoek
    Barbara A Hutten
    Kristin Jochmans
    Carolien AM Koks
    Walter KH Kuchenbecker
    Ben Willem J Mol
    Helen L Torrance
    Hubertina CJ Scheepers
    Mary D Stephenson
    Harold R Verhoeve
    Jantien Visser
    Johanna IP de Vries
    Mariëtte Goddijn
    Saskia Middeldorp
    Trials, 16
  • [22] Prevention of preeclampsia in high-risk patients with low-molecular-weight heparin: a meta-analysis
    Wang, Xiaoyi
    Gao, Hong
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2020, 33 (13): : 2202 - 2208
  • [23] Inherited and acquired thrombophilia in Indian women experiencing unexplained recurrent pregnancy loss
    Patil, Rucha
    Ghosh, Kanjaksha
    Vora, Sonal
    Shetty, Shrimati
    BLOOD CELLS MOLECULES AND DISEASES, 2015, 55 (03) : 200 - 205
  • [24] Low molecular weight heparin treatment and impact of inherited thrombophilia type in pregnancies with previous adverse outcome
    Aracic, Nada
    Roje, Damir
    Hofman, Irena Drmic
    Capkun, Vesna
    Stefanovic, Vedran
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (03): : 306 - 310
  • [25] Comparison between Fondaparinux and Low-Molecular-Weight Heparin in Patients with Acute Coronary Syndrome: A Meta-Analysis
    Qiao, Jianzhong
    Zhang, Xinlin
    Zhang, Jingmei
    Li, Peiwen
    Xu, Biao
    Wang, Shang
    Jiang, He
    Shen, Yu
    Wang, Kun
    CARDIOLOGY, 2016, 133 (03) : 163 - 172
  • [26] Therapeutic benefit of low-molecular-weight heparin in women with recurrent abortions
    Koerber, K.
    Kiesewetter, H.
    Radtke, H.
    Schmidt, F. P.
    Becker, R.
    Maas, S.
    Ristau, B.
    Baumgarten, S.
    Pruss, A.
    PHLEBOLOGIE, 2012, 41 (03) : 129 - +
  • [27] Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis
    Cruz-Lemini, Monica
    Carlos Vazquez, Juan
    Ullmo, Johana
    Llurba, Elisa
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (02) : S1126 - +
  • [28] Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
    Xia, Hui
    Wang, Ziyao
    Tian, Min
    Liu, Zunjing
    Zhou, Zhenhua
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [29] Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia
    Kupferminc, Michael
    Rimon, Eli
    Many, Ariel
    Maslovitz, Sharon
    Lessing, Joseph B.
    Gamzu, Ronni
    BLOOD COAGULATION & FIBRINOLYSIS, 2011, 22 (02) : 123 - 126
  • [30] Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage
    Elmahashi M.O.
    Elbareg A.M.
    Essadi F.M.
    Ashur B.M.
    Adam I.
    BMC Research Notes, 7 (1)